BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33090636)

  • 21. lncRNA KTN1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑505‑3p.
    Mu Y; Tang Q; Feng H; Zhu L; Wang Y
    Oncol Rep; 2020 Dec; 44(6):2645-2655. PubMed ID: 33125151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC00606 promotes glioblastoma progression through sponge miR-486-3p and interaction with ATP11B.
    Dong N; Qi W; Wu L; Li J; Zhang X; Wu H; Zhang W; Jiang J; Zhang S; Fu W; Liu Q; Qi G; Wang L; Lu Y; Luo J; Kong Y; Liu Y; Zhao RC; Wang J
    J Exp Clin Cancer Res; 2024 May; 43(1):139. PubMed ID: 38725030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095.
    Ren J; Yang Y; Xue J; Xi Z; Hu L; Pan SJ; Sun Q
    Biochem Biophys Res Commun; 2018 Feb; 496(2):712-718. PubMed ID: 29360452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.
    Zhou Y; Dai W; Wang H; Pan H; Wang Q
    Biochem Biophys Res Commun; 2018 Jun; 500(4):966-972. PubMed ID: 29715460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
    Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
    Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA linc00645 promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-205-3p-ZEB1 axis in glioma.
    Li C; Zheng H; Hou W; Bao H; Xiong J; Che W; Gu Y; Sun H; Liang P
    Cell Death Dis; 2019 Sep; 10(10):717. PubMed ID: 31558707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
    Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
    Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA GAPLINC promotes the growth and metastasis of glioblastoma by sponging miR-331-3p.
    Chen HH; Zong J; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):262-270. PubMed ID: 30657584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
    Zhang S; Liao K; Miao Z; Wang Q; Miao Y; Guo Z; Qiu Y; Chen B; Ren L; Wei Z; Lin Y; Lu X; Qiu Y
    Neuro Oncol; 2019 Oct; 21(10):1284-1296. PubMed ID: 31504797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.
    Liu Y; Xu N; Liu B; Huang Y; Zeng H; Yang Z; He Z; Guo H
    Oncotarget; 2016 Jul; 7(28):43835-43851. PubMed ID: 27270310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LINC01579 promotes cell proliferation by acting as a ceRNA of miR-139-5p to upregulate EIF4G2 expression in glioblastoma.
    Chai Y; Xie M
    J Cell Physiol; 2019 Dec; 234(12):23658-23666. PubMed ID: 31187495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells.
    Wu AC; Yang WB; Chang KY; Lee JS; Liou JP; Su RY; Cheng SM; Hwang DY; Kikkawa U; Hsu TI; Wang CY; Chang WC; Chen PY; Chuang JY
    J Exp Clin Cancer Res; 2022 Feb; 41(1):47. PubMed ID: 35109908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1.
    Li Y; He ZC; Zhang XN; Liu Q; Chen C; Zhu Z; Chen Q; Shi Y; Yao XH; Cui YH; Zhang X; Wang Y; Kung HF; Ping YF; Bian XW
    Cancer Lett; 2018 Mar; 416():66-74. PubMed ID: 29196129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313.
    Shao L; He Q; Liu Y; Liu X; Zheng J; Ma J; Liu L; Li H; Li Z; Xue Y
    Cell Death Dis; 2019 Aug; 10(9):629. PubMed ID: 31427569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma.
    Cui T; Bell EH; McElroy J; Liu K; Sebastian E; Johnson B; Gulati PM; Becker AP; Gray A; Geurts M; Subedi D; Yang L; Fleming JL; Meng W; Barnholtz-Sloan JS; Venere M; Wang QE; Robe PA; Haque SJ; Chakravarti A
    Mol Cancer Res; 2021 Jan; 19(1):48-60. PubMed ID: 32973101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
    Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D
    Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.
    Li Y; Li W; Zeng X; Tang X; Zhang S; Zhong F; Peng X; Zhong Y; Rosol TJ; Deng X; Liu Z; Peng S; Peng X
    Oncogene; 2019 Nov; 38(47):7234-7248. PubMed ID: 31477833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.